Geron Corporation
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.
Geron Corporation (GERN) - Total Assets
Latest total assets as of September 2025: $567.38 Million USD
Based on the latest financial reports, Geron Corporation (GERN) holds total assets worth $567.38 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Geron Corporation - Total Assets Trend (1996–2024)
This chart illustrates how Geron Corporation’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Geron Corporation - Asset Composition Analysis
Current Asset Composition (December 2024)
Geron Corporation's total assets of $567.38 Million consist of 82.7% current assets and 17.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 13.3% |
| Accounts Receivable | $38.80 Million | 6.5% |
| Inventory | $38.71 Million | 6.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1996–2024)
This chart illustrates how Geron Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Geron Corporation's current assets represent 82.7% of total assets in 2024, a decrease from 86.8% in 1996.
- Cash Position: Cash and equivalents constituted 13.3% of total assets in 2024, down from 43.1% in 1996.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 1996.
- Asset Diversification: The largest asset category is accounts receivable at 6.5% of total assets.
Geron Corporation Competitors by Total Assets
Key competitors of Geron Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Geron Corporation - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Geron Corporation generates 0.13x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Geron Corporation is currently not profitable relative to its asset base.
Geron Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.96 | 2.89 | 6.46 |
| Quick Ratio | 4.87 | 2.74 | 6.48 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $434.63 Million | $ 260.12 Million | $ 168.92 Million |
Geron Corporation - Advanced Valuation Insights
This section examines the relationship between Geron Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.18 |
| Latest Market Cap to Assets Ratio | 1.46 |
| Asset Growth Rate (YoY) | 50.7% |
| Total Assets | $593.78 Million |
| Market Capitalization | $868.81 Million USD |
Valuation Analysis
Above Book Valuation: The market values Geron Corporation's assets above their book value (1.46 x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Geron Corporation's assets grew by 50.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Geron Corporation (1996–2024)
The table below shows the annual total assets of Geron Corporation from 1996 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $593.78 Million | +50.68% |
| 2023-12-31 | $394.08 Million | +106.78% |
| 2022-12-31 | $190.57 Million | -15.69% |
| 2021-12-31 | $226.03 Million | -16.51% |
| 2020-12-31 | $270.73 Million | +63.57% |
| 2019-12-31 | $165.52 Million | -10.67% |
| 2018-12-31 | $185.28 Million | +67.96% |
| 2017-12-31 | $110.31 Million | -15.31% |
| 2016-12-31 | $130.25 Million | -12.44% |
| 2015-12-31 | $148.76 Million | -13.77% |
| 2014-12-31 | $172.51 Million | +156.16% |
| 2013-12-31 | $67.34 Million | -32.52% |
| 2012-12-31 | $99.80 Million | -37.64% |
| 2011-12-31 | $160.05 Million | -31.48% |
| 2010-12-31 | $233.58 Million | +29.49% |
| 2009-12-31 | $180.38 Million | +2.36% |
| 2008-12-31 | $176.22 Million | -19.50% |
| 2007-12-31 | $218.90 Million | -0.86% |
| 2006-12-31 | $220.80 Million | +9.72% |
| 2005-12-31 | $201.24 Million | +52.60% |
| 2004-12-31 | $131.87 Million | +11.65% |
| 2003-12-31 | $118.11 Million | +94.69% |
| 2002-12-31 | $60.67 Million | -36.95% |
| 2001-12-31 | $96.23 Million | -15.61% |
| 2000-12-31 | $114.03 Million | +79.01% |
| 1999-12-31 | $63.70 Million | +43.15% |
| 1998-12-31 | $44.50 Million | +70.50% |
| 1997-12-31 | $26.10 Million | -9.38% |
| 1996-12-31 | $28.80 Million | -- |